Cellebrite DI (CLBT) Total Liabilities (2020 - 2025)

Cellebrite DI (CLBT) has reported Total Liabilities for 6 consecutive years, with $454.5 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Total Liabilities rose 28.2% year-over-year to $454.5 million; the TTM figure through Dec 2025 stood at $454.5 million (up 28.2% YoY), while the FY2025 annual figure was $454.5 million, up 28.2% from the prior year.
• Total Liabilities came in at $454.5 million for Q4 2025 at Cellebrite DI, up from $386.6 million in the prior quarter.
• The five-year high for Total Liabilities was $596.7 million in Q2 2024, with the low at $293.0 million in Q3 2022.
• Average Total Liabilities over 5 years is $402.4 million, with a median of $382.8 million recorded in 2025.
• Across the five-year window, Total Liabilities jumped 107.21% in 2021 and tumbled 37.68% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $413.1 million in 2021, then decreased by 20.26% to $329.4 million in 2022, then soared by 51.38% to $498.7 million in 2023, then declined by 28.9% to $354.5 million in 2024, then advanced by 28.2% to $454.5 million in 2025.
• According to Business Quant data, Total Liabilities over the past three periods registered $454.5 million, $386.6 million, and $379.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.